Observational study on the application of different esketamine gargle doses for the prevention of postoperative sore throat after laryngeal mask airway insertion
Frontiers in Pharmacology · 07.08.2026 · 17
DOI: 10.3389/fphar.2026.1882856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.08.2026. Verfasst von Le Bo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huaian, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ketamine gargle is considered a highly effective measure for preventing postoperative sore throat (POST). This randomized controlled study aimed to explore the efficacy, safety, and optimal dosage of esketamine gargle for preventing POST following laryngeal mask airway insertion.
Methods
A total of 150 patients were randomly assigned to receive normal saline (NS), 25 mg, or 50 mg of esketamine gargle at a 1:1:1 ratio for 30 s prior to general anesthesia. The primary outcomes were the incidence of POST at 2, 6, and 24 h postoperatively. The secondary outcomes included the severity of POST at 2, 6, and 24 h postoperatively, along with the incidence and severity of dysphagia and hoarseness. Other outcomes included the incidence of the first intubation attempt, repositioning during surgery, convert to tracheal intubation, SpO 2 < 90%, blood stain on the laryngeal mask airway, tachycardia and hypertension following gargling, intraoperative peak airway pressure, and end - tidal carbon dioxide partial pressure (PetCO 2 ).
Results
The incidence of POST at 2, 6, and 24 h postoperatively was 32%, 10%, and 12%; 22%, 8%, and 8%; and 12%, 6%, and 4%, respectively, with a statistically significant difference among groups at 2 h postoperatively ( P = 0.007). In comparison with the NS group, the incidence of POST at 2 h postopertively in the 25 mg group was significantly lower (32% vs. 10%, P = 0.013). No statistically significant differences were observed in the remaining outcomes.
Conclusion
Esketamine gargle is effective and safe for preventing POST following laryngeal mask airway insertion, and a dose of 25 mg is recommended. Clinical Trial Registration ChiCTR2500099787.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huaian, China.
- Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
Zitieren
APA
Bo, L., Chen, Y., Sun, L., Zhai, P., Jiang, Y., Xu, X., & Xiong, X. (2026). Observational study on the application of different esketamine gargle doses for the prevention of postoperative sore throat after laryngeal mask airway insertion. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1882856
Vancouver
Bo L, Chen Y, Sun L, Zhai P, Jiang Y, Xu X, et al. Observational study on the application of different esketamine gargle doses for the prevention of postoperative sore throat after laryngeal mask airway insertion. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1882856
BibTeX
@article{Bo2026,
author = {Bo, Le and Chen, Yi and Sun, Linsen and Zhai, Peng and Jiang, Yan and Xu, Xiaoxiao and Xiong, Xiangsheng},
title = {Observational study on the application of different esketamine gargle doses for the prevention of postoperative sore throat after laryngeal mask airway insertion},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1882856}
}
EUVIMED